Rockefeller Capital Management L.P. Boosts Stake in Omega Healthcare Investors, Inc. (NYSE:OHI)

Rockefeller Capital Management L.P. increased its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 0.7% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 217,727 shares of the real estate investment trust’s stock after buying an additional 1,491 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in Omega Healthcare Investors were worth $8,862,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the company. Versant Capital Management Inc purchased a new position in shares of Omega Healthcare Investors during the second quarter worth approximately $26,000. UMB Bank n.a. grew its position in Omega Healthcare Investors by 353.4% during the 3rd quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 516 shares during the last quarter. DiNuzzo Private Wealth Inc. acquired a new position in Omega Healthcare Investors in the third quarter valued at $33,000. V Square Quantitative Management LLC raised its holdings in shares of Omega Healthcare Investors by 49.5% in the third quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock valued at $40,000 after buying an additional 323 shares during the last quarter. Finally, Truvestments Capital LLC acquired a new stake in shares of Omega Healthcare Investors during the third quarter worth about $43,000. Institutional investors and hedge funds own 65.25% of the company’s stock.

Insider Buying and Selling

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares of the company’s stock, valued at $4,025,000. This represents a 36.19 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. This represents a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Stock Down 0.7 %

OHI stock opened at $39.54 on Wednesday. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10. The company’s 50-day moving average price is $40.56 and its 200 day moving average price is $37.53. Omega Healthcare Investors, Inc. has a 52 week low of $27.53 and a 52 week high of $44.42. The company has a market cap of $10.67 billion, a P/E ratio of 29.07, a P/E/G ratio of 1.24 and a beta of 0.98.

Omega Healthcare Investors Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were paid a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a dividend yield of 6.78%. The ex-dividend date was Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is 197.06%.

Wall Street Analyst Weigh In

Several analysts have commented on OHI shares. Scotiabank upped their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research note on Monday, August 26th. BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target for the company in a research note on Thursday, October 31st. Berenberg Bank initiated coverage on Omega Healthcare Investors in a report on Friday, October 18th. They set a “buy” rating and a $45.00 price target for the company. Royal Bank of Canada upped their price objective on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research report on Monday, November 11th. Finally, Truist Financial lifted their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a report on Wednesday, September 4th. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $40.00.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.